CMO Troy achieves quest for brand ownership

Contractor Troy Manufacturing, after 20 years of making the topical analgesic pain reliever Stopain for DRJ Group, will now begin marketing it. Troy has bought the rights to the drug, thereby fulfilling its ambition. "If we had to be a contract manufacturer first, then so be it," says VP Anthony Cicini, in a local press report, "Getting out of the contract manufacturing business was by design, not by circumstance." Story

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.